Outset Medical Inc
OM15.130USD
+0.090+0.60%
交易中 （美东）报价延迟15分钟
268.13M总市值
亏损市盈率 TTM
关于 Outset Medical Inc 公司
Outset Medical, Inc. 是一家医疗技术公司。该公司提供 Tablo 血液透析系统 (Tablo)，这是一种用于血液透析的单一企业解决方案，由一个紧凑型控制台组成，该控制台集成了水净化、按需透析液生产和先进的软件及连接功能。该公司从头开始设计 Tablo，使其成为一种单一企业解决方案，可在整个护理过程中使用，让几乎任何人都可以随时随地进行透析。Tablo 系统由 Tablo 控制台、Tablo 墨盒和 Tablo 数据生态系统等组件组成。Tablo 控制台是一种紧凑、移动且多功能的机器，由集成的水净化、按需透析液生产系统和带 3D 动画的触摸屏界面组成。它还提供各种关键平台，例如面向客户的门户 TabloHub、面向患者的门户 MyTablo 和内部数据分析平台 TabloDash。
公司简介
公司代码OM
公司名称Outset Medical Inc
上市日期Sep 15, 2020
CEOMs. Leslie L. Trigg
员工数量354
证券类型Ordinary Share
年结日Sep 15
公司地址3052 Orchard Drive
城市SAN JOSE
上市交易所NASDAQ Global Select Consolidated
国家United States of America
邮编95134
电话16692318200
网址https://outsetmedical.com/
公司代码OM
上市日期Sep 15, 2020
CEOMs. Leslie L. Trigg
公司高管
名称
名称/职务
职务
持股
持股变动
Ms. Leslie L. Trigg
Ms. Leslie L. Trigg
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
69.22K
+1580.17%
Mr. Marc Nash
Mr. Marc Nash
Senior Vice President - Operations and Research and Development
Senior Vice President - Operations and Research and Development
35.25K
+532.30%
Mr. Patrick T. (Pat) Hackett
Mr. Patrick T. (Pat) Hackett
Independent Director
Independent Director
22.95K
+64.31%
Mr. Brent D. Lang
Mr. Brent D. Lang
Independent Director
Independent Director
10.25K
+706.77%
Ms. Karen Drexler
Ms. Karen Drexler
Independent Director
Independent Director
9.22K
+3711.98%
Mrs. Brittni Mcgill
Mrs. Brittni Mcgill
Chief Nursing Officer
Chief Nursing Officer
--
--
Mr. John L. Brottem
Mr. John L. Brottem
General Counsel, Secretary
General Counsel, Secretary
--
--
Mr. D. Keith Grossman
Mr. D. Keith Grossman
Lead Independent Director
Lead Independent Director
--
--
Ms. Andrea L. Saia
Ms. Andrea L. Saia
Independent Director
Independent Director
--
--
Ms. Renee M. Gaeta, CPA
Ms. Renee M. Gaeta, CPA
Chief Financial Officer
Chief Financial Officer
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Ms. Leslie L. Trigg
Ms. Leslie L. Trigg
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
69.22K
+1580.17%
Mr. Marc Nash
Mr. Marc Nash
Senior Vice President - Operations and Research and Development
Senior Vice President - Operations and Research and Development
35.25K
+532.30%
Mr. Patrick T. (Pat) Hackett
Mr. Patrick T. (Pat) Hackett
Independent Director
Independent Director
22.95K
+64.31%
Mr. Brent D. Lang
Mr. Brent D. Lang
Independent Director
Independent Director
10.25K
+706.77%
Ms. Karen Drexler
Ms. Karen Drexler
Independent Director
Independent Director
9.22K
+3711.98%
Mrs. Brittni Mcgill
Mrs. Brittni Mcgill
Chief Nursing Officer
Chief Nursing Officer
--
--
收入明细
单位: USD更新时间: 7月6日 周日
单位: USD更新时间: 7月6日 周日
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
业务USD
名称
营收
占比
Consumables
14.20M
47.74%
Services and other revenue
8.46M
28.43%
Consoles
7.09M
23.83%
暂无数据
业务
地区
业务USD
名称
营收
占比
Consumables
14.20M
47.74%
Services and other revenue
8.46M
28.43%
Consoles
7.09M
23.83%
股东统计
更新时间: 6月14日 周六
更新时间: 6月14日 周六
持股股东
股东类型
持股股东
持股股东
占比
Fidelity Management & Research Company LLC
14.55%
Durable Capital Partners LP
9.82%
Alyeska Investment Group, L.P.
9.61%
PFM Health Sciences, LP
9.51%
T. Rowe Price Investment Management, Inc.
9.05%
Other
47.47%
持股股东
持股股东
占比
Fidelity Management & Research Company LLC
14.55%
Durable Capital Partners LP
9.82%
Alyeska Investment Group, L.P.
9.61%
PFM Health Sciences, LP
9.51%
T. Rowe Price Investment Management, Inc.
9.05%
Other
47.47%
股东类型
持股股东
占比
Hedge Fund
40.58%
Investment Advisor
31.55%
Investment Advisor/Hedge Fund
9.99%
Private Equity
4.70%
Individual Investor
2.08%
Venture Capital
0.94%
Corporation
0.63%
Research Firm
0.28%
Bank and Trust
0.12%
Other
9.13%
机构持股
更新时间: 7月1日 周二
更新时间: 7月1日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q2
347
16.11M
90.89%
+12.67M
2025Q1
363
14.91M
84.25%
+11.40M
2024Q4
375
22.97M
42.67%
-34.22M
2024Q3
383
28.58M
54.40%
-41.22M
2024Q2
397
50.60M
97.17%
-19.65M
2024Q1
406
52.26M
101.52%
-18.15M
2023Q4
416
54.21M
107.73%
-7.17M
2023Q3
407
56.98M
114.62%
-11.76M
2023Q2
399
56.04M
113.10%
-11.31M
2023Q1
408
55.02M
111.94%
-9.31M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Fidelity Management & Research Company LLC
2.58M
14.55%
+2.35M
+1040.39%
Mar 31, 2025
Durable Capital Partners LP
1.74M
9.82%
+1.74M
--
Mar 31, 2025
Alyeska Investment Group, L.P.
1.70M
9.61%
+1.70M
--
Mar 31, 2025
PFM Health Sciences, LP
1.69M
9.51%
+1.69M
--
Mar 31, 2025
T. Rowe Price Investment Management, Inc.
1.60M
9.05%
+1.39M
+659.32%
Mar 31, 2025
Woodline Partners LP
1.33M
7.48%
+1.33M
--
Mar 31, 2025
The Vanguard Group, Inc.
173.32K
0.98%
-602.00
-0.35%
Mar 31, 2025
MFS Investment Management
840.25K
4.74%
+840.25K
--
Mar 31, 2025
Perceptive Advisors LLC
833.33K
4.7%
+833.33K
--
Mar 31, 2025
Marshall Wace LLP
650.26K
3.67%
+650.26K
--
Mar 31, 2025
查看更多
持股ETF
更新时间: 8月2日 周六
更新时间: 8月2日 周六
机构名称
占比
iShares Micro-Cap ETF
0.06%
iShares Russell 2000 Value ETF
0.01%
iShares Russell 2000 Growth ETF
0.01%
Global X Russell 2000 ETF
0.01%
iShares Russell 2000 ETF
0.01%
Proshares Ultra Russell 2000
0.01%
ProShares UltraPro Russell2000
0.01%
ProShares Hedge Replication ETF
0.01%
Avantis US Small Cap Equity ETF
0.01%
SPDR S&P Health Care Equipment ETF
0%
查看更多
iShares Micro-Cap ETF
占比0.06%
iShares Russell 2000 Value ETF
占比0.01%
iShares Russell 2000 Growth ETF
占比0.01%
Global X Russell 2000 ETF
占比0.01%
iShares Russell 2000 ETF
占比0.01%
Proshares Ultra Russell 2000
占比0.01%
ProShares UltraPro Russell2000
占比0.01%
ProShares Hedge Replication ETF
占比0.01%
Avantis US Small Cap Equity ETF
占比0.01%
SPDR S&P Health Care Equipment ETF
占比0%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
Mar 18, 2025
Merger
15<1
Mar 18, 2025
Merger
15<1
Mar 18, 2025
Merger
15<1
Mar 18, 2025
Merger
15<1
公告日期
类型
比率
Mar 18, 2025
Merger
15<1
Mar 18, 2025
Merger
15<1
Mar 18, 2025
Merger
15<1
Mar 18, 2025
Merger
15<1
